Cite
HARVARD Citation
Goyal, S. et al. (2018). Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study. Leukemia & lymphoma. 59 (2), pp. 357-362. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Goyal, S. et al. (2018). Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study. Leukemia & lymphoma. 59 (2), pp. 357-362. [Online].